chr3-33153265-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015551.2(SUSD5):āc.1367A>Gā(p.Glu456Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00242 in 1,613,920 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015551.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00203 AC: 308AN: 152098Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00160 AC: 399AN: 249174Hom.: 0 AF XY: 0.00160 AC XY: 216AN XY: 135174
GnomAD4 exome AF: 0.00246 AC: 3591AN: 1461704Hom.: 9 Cov.: 31 AF XY: 0.00239 AC XY: 1735AN XY: 727134
GnomAD4 genome AF: 0.00203 AC: 309AN: 152216Hom.: 1 Cov.: 32 AF XY: 0.00175 AC XY: 130AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2022 | The c.1367A>G (p.E456G) alteration is located in exon 5 (coding exon 5) of the SUSD5 gene. This alteration results from a A to G substitution at nucleotide position 1367, causing the glutamic acid (E) at amino acid position 456 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at